Nagarkatti N

No ORCID on file · 2 papers in corpus

observational 2022

Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites

Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100913

OBJECTIVE: To examine clinicopathologic characteristics and oncologic outcomes of patients diagnosed with Mullerian adenosarcoma and to evaluate ovarian preservation as a practical management option in early-stage disease. METHODS: A retro…

lab-animal 2020

Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma

Gynecologic Oncology ·doi:10.1016/j.ygyno.2020.06.484

OBJECTIVE: Whole-exome-sequencing (WES) studies reported c-MYC gene-amplification and HUWE1 gene deletion/mutations in a significant number of cervical-cancer-patients (CC) suggesting HUWE1/c-MYC pathway as potential therapeutic target. We …